Aerie Pharmaceuticals Inc (AERI) is around the top of the Drug Manufacturers - Specialty & Generic industry according to InvestorsObserver. AERI received an overall rating of 67, which means that it scores higher than 67 percent of all stocks. Aerie Pharmaceuticals Inc also achieved a score of 93 in the Drug Manufacturers - Specialty & Generic industry, putting it above 93 percent of Drug Manufacturers - Specialty & Generic stocks. Drug Manufacturers - Specialty & Generic is ranked 139 out of the 148 industries.
These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.
Is Aerie Pharmaceuticals Inc (AERI) a Good Choice in Drug Manufacturers - Specialty & Generic Monday?
AERI has an Overall Score of 67. Find out what this means to you and get the rest of the rankings on AERI!